GlobeNewswire by notified

Aerospike 6 on AWS Graviton2 Delivers 1.6x Improvement in Price-Performance

Share
  • New benchmark of Aerospike 6 deployed on AWS Graviton2 processors delivers 25 million transactions per second with 99% under 1 millisecond
  • Announcement follows the recent launch of Aerospike Cloud on AWS 

MOUNTAIN VIEW, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Aerospike, Inc., the real-time data platform leader, today announced a new release of Aerospike 6 running on AWS Graviton2-powered Amazon Elastic Compute Cloud (Amazon EC2) instances. Detailed in a new benchmark report, Achieve Exceptional Price-Performance for Real-time Workloads with Aerospike and AWS Graviton2, Aerospike 6 on AWS Graviton2 delivers proven price-performance benefits of up to an 18% increase in throughput while maintaining up to 27% reduction in cost. The test measures AWS Graviton2–powered Amazon EC2 instances versus comparable x86-based instances running Aerospike 6, with 99% of the transactions completed in 1 millisecond or less. (Source: Hakha Momeni, AWSGraviton Price-Performance Calculations).

Strong Sustainability Benefits

Aerospike is known for reducing servers and carbon footprint by 80%. A recent IEEE paper cited the importance of software on hardware affecting energy consumption. Additionally, AWS Graviton2–based Amazon EC2 instances offer better performance for greater energy efficiency, which helps customers meet their sustainability targets.

No Performance Tradeoff 

“AWS Graviton2–based instances provide secure, resizable compute in the cloud and enhanced price-performance for workloads in Amazon EC2,” said Andrew Affolter, senior engineering leader at Snap Inc. “With Aerospike running on AWS Graviton2, we anticipate even better compute and price-performance benefits.” 

“Since its inception, the Aerospike Real-time Data Platform was designed to fully leverage the latest innovations in compute, memory and networking technologies,” said Subbu Iyer, CEO of Aerospike. “The combination of Aerospike 6 running on the innovations delivered by AWS Graviton2 once again gives Aerospike a significant price-performance advantage over any other solution in the market today." 

“Powered by AWS Graviton2–based C6gn instances, Aerospike customers will experience significantly better price-performance and efficiency benefits than on other architectures,” said Raj Pai, vice president of Amazon EC2 Product Management, Amazon Web Services. “Aerospike 6 on AWS Graviton2 makes it ideal for compute-intensive applications such as gaming, distributed analytics, ad serving, financial services, telecommunications, IoT, and more.” 

Aerospike 6 running on AWS Graviton2–powered Amazon EC2 instances joins the recently announced Aerospike Cloud and the successful Aerospike Cloud Managed Service to allow customers to innovate further in the cloud. 

The Achieve Exceptional Price-Performance for Real-time Workloads with Aerospike and AWS Graviton2 benchmark will be showcased at re: Invent, November 28 - December 2 in Las Vegas. Visitors can experience demonstrations of Aerospike 6 running on AWS and Aerospike Cloud. You can learn more here.

Resources

About Aerospike

Aerospike unleashes the power of real-time data to meet the demands of The Right Now Economy. Global innovators and builders choose the Aerospike real-time, multi-model, NoSQL data platform for its predictable sub-millisecond performance at unlimited scale with dramatically reduced infrastructure costs. With support for strong consistency and globally distributed, multi-cloud environments, Aerospike is an essential part of the modern data stack for Adobe, Airtel, Criteo, DBS Bank, Experian, PayPal, Snap, Sony Interactive Entertainment and Wayfair. A global company, Aerospike is headquartered in Mountain View, California, with offices in London, Bangalore and Tel Aviv. 

Contact:

John Moran
Look Left Marketing
aerospike@lookleftmarketing.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Canadian Government Awards New Funding to General Fusion5.12.2023 02:00:00 CET | Press release

RICHMOND, Canada, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Today, General Fusion announced that Canada’s Strategic Innovation Fund (SIF) has awarded CA$5 million to support research and development to advance the company’s Magnetized Target Fusion (MTF) demonstration at its Richmond headquarters. Called LM26, this ground-breaking machine will progress major technical milestones required to commercialize zero-carbon fusion power by the early to mid-2030s. The funds are an addition to the existing contribution agreement with SIF, to support the development of General Fusion’s transformational technology. Fusion energy is the ultimate clean energy solution. It is what powers the sun and stars. It’s the process by which two light nuclei merge to form a heavier one, emitting a massive amount of energy. By 2100, the production and export of the Canadian industry’s fusion energy technology could provide up to $1.26 trillion in economic benefits to Canada. Additionally, fusion could completely offset

LeddarTech and Prospector Capital Corp. Announce Effectiveness of Registration Statement and December 13, 2023 Extraordinary General Meeting to Approve Business Combination4.12.2023 23:30:00 CET | Press release

QUEBEC CITY, Dec. 04, 2023 (GLOBE NEWSWIRE) -- LeddarTech Inc.® (“LeddarTech” or the “Company”), an automotive software company that provides patented disruptive AI-based low-level sensor fusion and perception software technology for ADAS and AD, and Prospector Capital Corp. (“Prospector”) (NASDAQ: PRSR, PRSRU, PRSRW), a publicly traded special-purpose acquisition company led by former Qualcomm President Derek Aberle and chaired by former Qualcomm Vice Chairman Steve Altman, today announced that on December 4, 2023 the U.S. Securities and Exchange Commission (the “SEC”) declared effective the Registration Statement on Form F-4, as amended, filed by LeddarTech Holdings Inc. (“Newco”) in connection with the previously announced proposed business combination (the “Business Combination”). The filing can be viewed in its entirety on the SEC’s website at www.sec.gov. Prospector also commenced mailing the definitive proxy statement/prospectus on December 4, 2023, which was included in the Reg

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 20234.12.2023 22:30:00 CET | Press release

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights11/30/2023 96,431,770 Total gross of voting rights: 96,431,770 Total net* of voting rights: 96,186,256 * Net total = total number of voting rights attached to shares – shares without voting rights Attachment PDF Version

Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.4.12.2023 22:16:59 CET | Press release

Aggregate gross proceeds of approximately €50.9 million (equivalent to approximately $53.8 million) received by NANOBIOTIX has increased to approximately €55.5 million (equivalent to approximately $58.7 million) extending its runway into mid’ 2025 PARIS and CAMBRIDGE, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces today the closing of the previously announced subscription by Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”) for 901,256 additional ordinary shares of the Company, in the form of restricted American Depositary Shares (“ADSs”), for an aggregate amount of $4.8 million, equivalent to €4.6 million1 (the “Remaining Placement Amount”, and the subscription transaction being the “Remaining Placement”), following the approval by the French Ministry of Economy of JJ

Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH4.12.2023 22:05:00 CET | Press release

The DMC recommended to continue the clinical trial without modification of the protocol, based on the pre-planned review of safety dataThe safety assessment was based on the review of safety data from more than 500 patients, including patients that have been treated with lanifibranor for more than 72 weeksThe DMC review remains consistent, confirming the good safety profile of lanifibranor Daix (France), Long Island City (New York, United States), December 4, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases with significant unmet medical needs, today announced the positive recommendation from the third meeting of the Data Monitoring Committee (DMC) to continue the NATiV3 Phase III clinical trial evaluating lanifibranor in patients with NASH without modification to the trial protocol. The DMC